230 related articles for article (PubMed ID: 21978260)
21. Diaminopropionic acid lipopeptides: characterization studies of polyplexes aimed at pDNA delivery.
Viola JR; Strömberg R; Simonson OE; Andaloussi SE; Smith CI; Murtola M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5635-8. PubMed ID: 22858100
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells.
Sakamoto N; Rosenberg AS
J Immunol; 2011 Apr; 186(8):5004-11. PubMed ID: 21402897
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
Dohmen C; Wagner E
Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
[TBL] [Abstract][Full Text] [Related]
24. Free uptake of cell-penetrating peptides by fission yeast.
Parenteau J; Klinck R; Good L; Langel U; Wellinger RJ; Elela SA
FEBS Lett; 2005 Aug; 579(21):4873-8. PubMed ID: 16111683
[TBL] [Abstract][Full Text] [Related]
25. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
[TBL] [Abstract][Full Text] [Related]
26. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA.
Judge AD; Sood V; Shaw JR; Fang D; McClintock K; MacLachlan I
Nat Biotechnol; 2005 Apr; 23(4):457-62. PubMed ID: 15778705
[TBL] [Abstract][Full Text] [Related]
27. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
Li H; Tsui T
Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
[TBL] [Abstract][Full Text] [Related]
28. A peptide-based vector for efficient gene transfer in vitro and in vivo.
Lehto T; Simonson OE; Mäger I; Ezzat K; Sork H; Copolovici DM; Viola JR; Zaghloul EM; Lundin P; Moreno PM; Mäe M; Oskolkov N; Suhorutšenko J; Smith CI; Andaloussi SE
Mol Ther; 2011 Aug; 19(8):1457-67. PubMed ID: 21343913
[TBL] [Abstract][Full Text] [Related]
29. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
30. Effect of sodium acetate on cell proliferation and induction of proinflammatory cytokines: a preliminary evaluation.
Sun J; Bi L; Chi Y; Aoki K; Misumi J
Food Chem Toxicol; 2005 Dec; 43(12):1773-80. PubMed ID: 16005558
[TBL] [Abstract][Full Text] [Related]
31. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
Chugh A; Eudes F
FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
[TBL] [Abstract][Full Text] [Related]
32. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
33. Human-protein-derived peptides for intracellular delivery of biomolecules.
Haas AK; Maisel D; Adelmann J; von Schwerin C; Kahnt I; Brinkmann U
Biochem J; 2012 Mar; 442(3):583-93. PubMed ID: 22150630
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
35. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Mäe M; Andaloussi SE; Lehto T; Langel U
Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
[TBL] [Abstract][Full Text] [Related]
36. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
[TBL] [Abstract][Full Text] [Related]
37. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
[TBL] [Abstract][Full Text] [Related]
38. Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo.
Boisguerin P; Redt-Clouet C; Franck-Miclo A; Licheheb S; Nargeot J; Barrère-Lemaire S; Lebleu B
J Control Release; 2011 Dec; 156(2):146-53. PubMed ID: 21839124
[TBL] [Abstract][Full Text] [Related]
39. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
[TBL] [Abstract][Full Text] [Related]
40. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
